[{"id":"b57d5d3c-7788-43e0-aa01-2ce50325f709","acronym":"","url":"https://clinicaltrials.gov/study/NCT01861509","created_at":"2021-01-18T08:19:27.113Z","updated_at":"2024-07-02T16:36:54.812Z","phase":"Phase 1","brief_title":"BP-C1 in Metastatic Breast Cancer Patients","source_id_and_acronym":"NCT01861509","lead_sponsor":"Meabco A/S","biomarkers":" IFNG • IL6 • TNFA • CXCL8 • IL2 • IL10 • IL1B • IL21 • IL4","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • CXCL8 • IL2 • IL10 • IL1B • IL21 • IL4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BP-C1"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 01/19/2014","start_date":" 01/19/2014","primary_txt":" Primary completion: 01/20/2016","primary_completion_date":" 01/20/2016","study_txt":" Completion: 01/20/2016","study_completion_date":" 01/20/2016","last_update_posted":"2019-10-07"}]